Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00954148 · ClinicalTrials.gov registry record · NA

Defining the Utility of PET/CT in the Follow-up of Patients With Solid Tumors

A NA study, sponsored by Dallas VA Medical Center.

Terminated
Registry status
NA
Development phase
53
Enrollment target

NCT00954148 is a NA study that was terminated before completion, run by Dallas VA Medical Center. The registered enrollment target is 53 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00954148, a NA study, was terminated before completion, sponsored by Dallas VA Medical Center.

TERMINATED
Registry status
NA
Development phase
53 participants
Enrollment target

Study Summary

This is a comparison, at this VA Hospital,of routine multi-visit and multi-testing for solid tumor recurrence in four tumor groups to a limited scheduled 5 visit history/physical with PET/CT only, over a five year period. The purpose is to show through utilization of the single most sensitive and specific test currently available-PET/CT-that survival for patients in follow-up can be improved.(Plus lowering medical costs and increasing patient confidence and compliance with follow-up appointments).

Interventions

  • PROCEDURE PET/CT
  • PROCEDURE NCCN recommendations for solid tumor post treatment

Trial Details

FieldValue
Enrollment Target 53 participants
Start Date 2009-09
Est. Completion 2010-06
Phase NA

Sponsor

Dallas VA Medical Center

20 total trials

What the Registry Record Tells You About NCT00954148

The ClinicalTrials.gov registry entry for NCT00954148 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dallas VA Medical Center, which has 20 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which PET/CT is the first listed.

NCT00954148 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00954148 about?

NCT00954148 is a clinical study titled "Defining the Utility of PET/CT in the Follow-up of Patients With Solid Tumors". This is a comparison, at this VA Hospital,of routine multi-visit and multi-testing for solid tumor recurrence in four tumor groups to a limited scheduled 5 visit history/physical with PET/CT only, over a five year period. The purpose is to show through utilization of the single most sensitive and sp...

What is the current status of trial NCT00954148?

This trial is currently terminated. It is a NA study. The enrollment target is 53 participants. The study started on 2009-09. Estimated completion is 2010-06.

What interventions are being tested in trial NCT00954148?

The interventions under investigation include: PET/CT (PROCEDURE), NCCN recommendations for solid tumor post treatment (PROCEDURE).

Who is sponsoring clinical trial NCT00954148?

This trial is sponsored by Dallas VA Medical Center, which has 20 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.